KMK Patient Journey Analysis Leads Global Pharma Brand To More Accurate Forecasting
A top ten pharmaceutical company contracted with KMK Consulting to provide a patient journey analysis on its recently introduced medication serving a small, rare disease patient population suffering with acute myeloid leukemia (AML). Forecasts based on market research of the patient journey were not being met, and senior management needed a reset based on a more evidence-based research approach of the patient journey. KMK was a proven resource to the client, demonstrating […]
Forecasting in CAR T- Cell Therapy Assists in Setting Client Expectations for Patient Deliveries
All Insights Share with Peers Share on facebook Share on twitter Share on linkedin Share on email Published On Project Background Chimeric antigen receptor (CAR) T-cell therapy is a cell-based gene therapy used to attack cancer by using the patient’s T cells, which have been altered in the lab, in order to find and destroy […]
Looking Ahead in Oncology
WHAT WILL YOU LEARN KOL Panel Discusses Cell and Gene Therapy Trends Join Lisa Logan and a group of oncology experts in discussing the possibilities of CAR T-cell therapy expansion to treat solid tumors as well as the implications on the current and future landscape of treatments across tumor types. Get this content Emailed
How to Reach Oncologists when Face-to-Face Interaction is Impossible
Introduction How do you reach oncologists when face-to-face interaction is no longer an option? Which social media channels are doctors using to gather medical information? In KMK’s Customer Value and Innovation Study we learned that oncologists working in breast cancer can be divided into two distinct groups with surprisingly different behaviors. The value of support […]
